Speaker illustration

Professor Ele Ferrannini

CNR – National Research Council, Pisa (Italy)

SGLT2 inhibitors and alteration of substrate metabolism.

Event: ESC Congress 2018

Topic: Diabetes and the Heart

Session: How do SGLT2 inhibitors and incretin-based therapy exert their effects on cardiovascular disease?


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb